Accounting for selection and correlation in the analysis of two-stage genome-wide association studies
暂无分享,去创建一个
[1] Allan R. Sampson,et al. Extension of a Two-Stage Conditionally Unbiased Estimator of the Selected Population to the Bivariate Normal Case , 2007 .
[2] Jack Bowden,et al. Unbiased estimation of odds ratios: combining genomewide association scans with replication studies , 2009, Genetic epidemiology.
[3] Sonja W. Scholz,et al. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. , 2009, Human molecular genetics.
[4] Jack Bowden,et al. Unbiased Estimation of Selected Treatment Means in Two‐Stage Trials , 2008, Biometrical journal. Biometrische Zeitschrift.
[5] Jack Bowden,et al. Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials , 2013, Biometrical journal. Biometrische Zeitschrift.
[6] Pak Chung Sham,et al. Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. , 2012, Human molecular genetics.
[7] R. Elston,et al. Optimal two‐stage genotyping in population‐based association studies , 2003, Genetic epidemiology.
[8] Harold B. Sackrowitz,et al. Two stage conditionally unbiased estimators of the selected mean , 1989 .
[9] Margaret Sullivan Pepe,et al. Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility. , 2012, Statistics in medicine.
[10] Nigel Stallard,et al. Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility , 2013, Statistics in medicine.
[11] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[12] C. Begg,et al. Two‐Stage Designs for Gene–Disease Association Studies , 2002, Biometrics.
[13] Jack Bowden,et al. Correcting for bias in the selection and validation of informative diagnostic tests , 2015, Statistics in medicine.
[14] Martin Posch,et al. Testing and estimation in flexible group sequential designs with adaptive treatment selection , 2005, Statistics in medicine.
[15] Sambasivarao Damaraju,et al. A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility , 2012, European Journal of Human Genetics.
[16] Frank Bretz,et al. Twenty‐five years of confirmatory adaptive designs: opportunities and pitfalls , 2015, Statistics in medicine.
[17] R. Prentice,et al. Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. , 2008, Biostatistics.
[18] W. Brannath,et al. Selection and bias—Two hostile brothers , 2009, Statistics in medicine.
[19] Margaret Sullivan Pepe,et al. Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility , 2009, Statistics in medicine.
[20] Allan R Sampson,et al. Drop‐the‐Losers Design: Normal Case , 2005, Biometrical journal. Biometrische Zeitschrift.
[21] C. Begg,et al. Two‐Stage Designs for Gene–Disease Association Studies with Sample Size Constraints , 2004, Biometrics.
[22] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[23] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[24] Alastair Forbes,et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility , 2007, Nature Genetics.
[25] John P. A. Ioannidis,et al. Validating, augmenting and refining genome-wide association signals , 2009, Nature Reviews Genetics.
[26] Juan Pablo Lewinger,et al. Methodological Issues in Multistage Genome-wide Association Studies. , 2009, Statistical science : a review journal of the Institute of Mathematical Statistics.
[27] D. Thomas,et al. Two‐Stage sampling designs for gene association studies , 2004, Genetic epidemiology.
[28] Frank Bretz,et al. TUTORIAL IN BIOSTATISTICS Adaptive designs for confirmatory clinical trials , 2022 .